LRND NEW YORK LIFE INVESTMENTS ET
NYLI US LC R&D L
26Q126Q2
26Q126Q2
All 11 quarters on paid plans 🔒
Institutional ownership by quarter
| Quarter | Holders | Shares held | Reported value | New | Added | Reduced | Sold out | Est. net buying |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 6 | 8,617,412 | $380.04M | 2 | 2 | 1 | 1 | $139.88M |
| 2026Q1 | 5 | 5,449,251 | $202.58M | 2 | 2 | 1 | 2 | $142.11M |
| All 11 quarters on paid plans 🔒 | ||||||||
2026Q2 top buys
| New York Life Investment Management LLC | Added | $140.26M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $515,281 |
| UBS Group AG | New | $14,068 |
| Sankala Group LLC | Added | $11,119 |
2026Q2 top sells
| GTS SECURITIES LLC | Sold out | -$831,032 |
| GOLDMAN SACHS GROUP INC | Reduced | -$98,126 |
2026Q2 largest holders
Export all holders (CSV) 🔒| Funds | Shares | Value | % of fund | Share change | Action |
|---|---|---|---|---|---|
| New York Life Investment Management LLC | 8,599,898 | $379.27M | 2.65% | 3,180,497 | Added |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,684 | $515,281 | 0.00% | 11,684 | New |
| GOLDMAN SACHS GROUP INC | 4,700 | $207,277 | 0.00% | -2,225 | Reduced |
| Sankala Group LLC | 810 | $37,527 | 0.03% | 240 | Added |
| UBS Group AG | 319 | $14,068 | 0.00% | 319 | New |
| MORGAN STANLEY | 1 | $54 | 0.00% | 0 | Unchanged |
Insider trades (Form 4)
Latest trades in LRND by directors, officers and 10% owners. Available on Pro 🔒